[HTML][HTML] Association of Exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non–small-cell lung cancer
VHF Lee, VPC Tin, T Choy, K Lam, C Choi… - Journal of Thoracic …, 2013 - Elsevier
Background: This study investigated whether there were differential survival outcomes to first-
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
[HTML][HTML] Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung …
VHF Lee, VPC Tin, T Choy, K Lam, C Choi… - Journal of Thoracic …, 2013 - jto.org
Background: This study investigated whether there were differential survival outcomes to first-
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer
VHF Lee, VPC Tin, T Choy, K Lam… - Journal of thoracic …, 2013 - pubmed.ncbi.nlm.nih.gov
Background This study investigated whether there were differential survival outcomes to first-
line tyrosine kinase inhibitors (TKI) in patients with metastatic non-small-cell lung cancer …
line tyrosine kinase inhibitors (TKI) in patients with metastatic non-small-cell lung cancer …
Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer.
VH Lee, VP Tin, TS Choy, KO Lam… - Journal of Thoracic …, 2013 - europepmc.org
Background This study investigated whether there were differential survival outcomes to first-
line tyrosine kinase inhibitors (TKI) in patients with metastatic non-small-cell lung cancer …
line tyrosine kinase inhibitors (TKI) in patients with metastatic non-small-cell lung cancer …
Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer
VHF Lee, PC Tin, TS Choy, KO Lam, CW Choi… - Journal of Thoracic …, 2013 - hub.hku.hk
Background: This study investigated whether there were differential survival outcomes to first-
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
[PDF][PDF] Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung …
C Choi, L Chung, JWH Tsang, PPY Ho… - Journal of Thoracic …, 2013 - core.ac.uk
Background: This study investigated whether there were differential survival outcomes to first-
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer …
[引用][C] Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung …
VHF Lee, VPC Tin, T Choy, K Lam, C Choi… - Journal of Thoracic …, 2013 - cir.nii.ac.jp
Association of Exon 19 and 21 EGFR Mutation Patterns with Treatment Outcome after First-Line
Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer | CiNii Research CiNii …
Tyrosine Kinase Inhibitor in Metastatic Non–Small-Cell Lung Cancer | CiNii Research CiNii …